FDA

The U.S. Food and Drug Administration announced Wednesday, Jan. 6, that U.S. Marshals, at the agency’s request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.

shadow
Sweet Leaf Tea - photo from FDA

The Sweet Leaf Tea Company has announced that it is voluntarily recalling Sweet Leaf Tea in 16 ounce glass bottles “out of an abundance of caution because of the possible presence of glass fragments.”

The company reports the glass shards were the result of breakage during the filling process. Consumers could potentially be cut or injured if ingested. The company had received four complaints of glass in the product at the time a press release from the FDA on Dec. 10. No injuries were reported.

shadow

While the American food supply is among the safest in the world, the Centers for Disease Control and Prevention (CDC) estimates that 1 in 6 Americans is sickened by foodborne illness annually, resulting in about 3,000 deaths each year.  It is estimated that the overall negative economic impact of foodborne illness in the United States, including medical costs, quality-of-life losses, lost productivity, and lost-life expectancy, may be as high as $77 billion per year.&nbsp

shadow

The U.S. Food and Drug Administration is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. Since the outbreak of the Ebola virus in West Africa, the FDA has seen and received consumer complaints about a variety of products claiming to either prevent the Ebola virus or treat the infection.

shadow

The U.S. Food and Drug Administration  approved Beleodaq (belinostat) Thursday, July 3 for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency’s accelerated approval program.

shadow

The U.S. Food and Drug Administration approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflammation), in adults 18 years through 65 years of age, on Thursday, April 17.

shadow